Ocera Therapeutics Inc (OCRX) financial statements (2020 and earlier)

Company profile

Business Address 555 TWIN DOLPHIN DRIVE
REDWOOD CITY, CA 94065
State of Incorp. CA
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2843474615
Cash and cash equivalents2536101615
Short-term investments473730 
Receivables 0000
Disposal group, including discontinued operation   3 
Prepaid expense and other current assets0
Other undisclosed current assets11101
Total current assets:2944484917
Noncurrent Assets
Property, plant and equipment00001
Long-term investments and receivables  42 
Long-term investments  42 
Intangible assets, net (including goodwill)1111
Goodwill1111 
Intangible assets, net (excluding goodwill)  00 
Deposits noncurrent assets0000 
Total noncurrent assets:11531
TOTAL ASSETS:3045535218
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:33223
Accounts payable  112
Accrued liabilities  221
Employee-related liabilities11   
Interest and dividends payable0    
Other undisclosed accounts payable and accrued liabilities22(1)(1) 
Debt10    
Disposal group, including discontinued operation   4 
Deferred revenue and credits    1
Other undisclosed current liabilities1111 
Total current liabilities:144373
Noncurrent Liabilities
Long-term debt and lease obligation 10 00
Long-term debt, excluding current maturities 10 00
Liabilities, other than long-term debt00   
Deferred revenue and credits00   
Other undisclosed noncurrent liabilities    0
Total noncurrent liabilities:010 00
Total liabilities:1413373
Stockholders' equity
Stockholders' equity attributable to parent1631504514
Additional paid in capital174163155127144
Accumulated other comprehensive income (loss) (0)(0)0(1)
Accumulated deficit(158)(131)(105)(81)(129)
Total stockholders' equity:1631504514
TOTAL LIABILITIES AND EQUITY:3045535218

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenue, net 0008
Gross profit:10008
Operating expenses(26)(26)(25)(15)(28)
Operating loss:(26)(26)(25)(15)(19)
Nonoperating income (expense)(1)(0)0(0)(1)
Other nonoperating expense    (1)
Interest and debt expense    (4)
Other undisclosed income from continuing operations before equity method investments, income taxes    1
Net loss:(27)(27)(25)(15)(23)
Other undisclosed net income (loss) attributable to parent 01(2) 
Net loss available to common stockholders, diluted:(27)(27)(23)(18)(23)

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(27)(27)(25)(15)(23)
Other undisclosed comprehensive income (loss)001(2)0
Comprehensive loss, net of tax, attributable to parent:(27)(27)(23)(18)(23)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: